Böyük Abubekir, Şanlı Öner, Erdem Selçuk, Tefik Tzevat, Özcan Faruk, Özlük Yasemin, Kılıçarslan Işın, Tunç Murat
Department of Urology, İstanbul University İstanbul School of Medicine, İstanbul, Turkey.
Department of Pathology, İstanbul University İstanbul School of Medicine, İstanbul, Turkey.
Turk J Urol. 2018 Jan;44(1):24-30. doi: 10.5152/tud.2017.48107. Epub 2017 Dec 19.
We aimed to compare the oncological outcomes of patients with variant urothelial histologies (VH) with pure urothelial histology (PUH) in bladder cancer (BC) patients.
This study includes 223 patients who underwent radical cystectomies (RCs) between September 2006 and July 2016 with complete follow-up data A retrospective screening was performed to identify the patients with PUH and VH. The primary outcomes of interest were pathological stage of disease at RC and disease-specific survival (DSS). For comparison of categorical variables, Fisher's exact test and Pearson chi- square and for continuous variables Wilcoxon rank-sum and Mann-Whitney U tests were used. Kaplan-Meier (KM) method was used for survival analysis and log-rank test was used for comparison of survival rates. Predictors of survival were detected with mulitivariable Cox-proportional hazards model including the variables such as gender, age, existence of VH, lymph node dissection (LND) type and pathological stage of the disease.
A moderate-degree correlation was detected between VH and pathological stages of RC (r=0.45, p<0.001). In PUH group, 39 (25.8%) of 151 patients died after a median follow-up of 20 (0-107) months; whereas 37 (51.4%) of 72 patients with VH died after a median follow-up of 16.5 (0-104) months (p<0.001). In terms of pathological stage, the number of patients with PUH and VH were at stages pT0-2 (n=100; 66.2% vs. n=19; 26.4%), pT3-4 (n=35; 23.2% vs. 38; 52.8%, and in 16 (10.6%) and 15 (20.8%) patients with LN positivity, respectively (p<0.001). KM survival analysis revealed a significantly decreased DSS in patients with VH compared to PUH (p<0.001). Meanwhile, pathological disease stage and existence of VH were found to be associated with decreased DSS in the multivariate model.
The present study revealed that VH is associated with advanced pathological tumor stage at RC and decreased DSS compared to patients with PUH in patients with BC.
我们旨在比较膀胱癌(BC)患者中具有变异尿路上皮组织学(VH)与纯尿路上皮组织学(PUH)患者的肿瘤学结局。
本研究纳入了2006年9月至2016年7月期间接受根治性膀胱切除术(RC)且有完整随访数据的223例患者。进行回顾性筛查以确定PUH和VH患者。主要关注的结局是RC时疾病的病理分期和疾病特异性生存(DSS)。对于分类变量的比较,使用Fisher精确检验和Pearson卡方检验;对于连续变量,使用Wilcoxon秩和检验和Mann-Whitney U检验。采用Kaplan-Meier(KM)方法进行生存分析,使用对数秩检验比较生存率。通过多变量Cox比例风险模型检测生存预测因素,该模型包括性别、年龄、VH的存在、淋巴结清扫(LND)类型和疾病的病理分期等变量。
检测到VH与RC的病理分期之间存在中度相关性(r = 0.45,p < 0.001)。在PUH组中,151例患者中有39例(25.8%)在中位随访20(0 - 107)个月后死亡;而72例VH患者中有37例(51.4%)在中位随访16.5(0 - 104)个月后死亡(p < 0.001)。在病理分期方面,PUH和VH患者处于pT0 - 2期的人数分别为100例(66.2%)和19例(26.4%),处于pT3 - 4期的人数分别为35例(23.2%)和38例(52.8%),淋巴结阳性的患者分别为16例(10.6%)和15例(20.8%)(p < 0.001)。KM生存分析显示,与PUH患者相比,VH患者的DSS显著降低(p < 0.001)。同时,在多变量模型中发现病理疾病分期和VH的存在与DSS降低相关。
本研究表明,与BC患者中的PUH患者相比,VH与RC时较高的病理肿瘤分期相关且DSS降低。